US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Arin Tactical Tail Risk ETF

95.16

-0.0934-0.10%

Post-market: 95.160.00000.00%16:10 EDT

Volume:1K

Turnover:127.00K

Market Cap:110.31M

PE:- -

High:95.37

Open:95.37

Low:95.03

Close:95.26

52wk High:95.59

52wk Low:45.10

Shares:1.16M

Float Shares:1.16M

Volume Ratio:1.10

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Why Archer and Joby Stocks Are Falling as Oil and Treasury Yields Rise

AstraZeneca’s ATTR-CM Imaging Sub-study Wraps Up, Setting the Stage for New Data Insights

Bond Yields at 5%, Oil at $120, VIX at 25? The Market's Nightmare Scenario Is Rapidly Becoming Reality

Intercont says not commenting on short-term market volatility

Capital Markets Warns of Rising Odds for a U.S. Stock Correction, Citing Midterm Election Risks and AI Trade Instability

Wall Street's Deceptive Calm Meets Bond Market's Stern Warning: As VIX Falls Silent, Are Treasury Yields the New Fear Barometer for Equities?

BridgeBio Pharma presents new analyses from Phase 3 ATTRibute-CM study

Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM

NZD/USD (NZDUSD) Is down 0.53% on Aug 28: Why It Happened

Ionis, AstraZeneca ATTR-CM trial did not meet primary endpoint

Japanese Shares Rise Ahead of Federal Reserve Chair's Rate Outlook; Oil Falls

MT Newswires Live

Bayer’s MOSAIC-TTR Study: Real-World Data Push for Acoramidis in ATTR-CM

BridgeBio Pharma doses first patient in ASCEND-ATTR trial

BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM

Alert Signals Intensify: UBS Flags U.S. Stock Market Fragility at Two-Year High, Echoing Pattern That Preceded VIX Spike

Alnylam to present new clinical data on ATTR, hypertension at ESC Congress

BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026

The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn

Banco Santander receives Federal Reserve approval for Webster acquisition

A Federal Reserve Stuck in Limbo

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/ATTR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATTR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATTR\",,,,,undefined,":{"symbol":"ATTR","market":"US","secType":"STK","nameCN":"Arin Tactical Tail Risk ETF","latestPrice":95.1639,"timestamp":1789588800000,"preClose":95.2573,"halted":0,"volume":1334,"hourTrading":{"tag":"盘后","latestPrice":95.1639,"preClose":95.1639,"latestTime":"16:10 EDT","volume":3,"amount":285.4917,"timestamp":1789589404690,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0009805022817149195,"floatShares":1159146,"shares":1159146,"eps":0,"marketStatus":"Post-Mkt","change":-0.0934,"latestTime":"09-16 17:21:39 EDT","open":95.37,"high":95.37,"low":95.025,"amount":127003,"amplitude":0.003622,"askPrice":142.54,"askSize":200,"bidPrice":47.52,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"exchange":"CBOE","adjPreClose":95.2573,"sharesOutstanding":989146,"nav":95.4,"aum":110582528.4,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":95.1639,"preClose":95.1639,"latestTime":"16:10 EDT","volume":3,"amount":285.4917,"timestamp":1789589404690,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.101933},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATTR\",,,,,undefined,":{"symbol":"ATTR","floatShares":1159146,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.101933,"shares":1159146,"dividePrice":0,"high":95.37,"amplitude":0.003622,"preClose":95.2573,"low":95.025,"week52Low":45.1,"pbRate":"--","week52High":95.585,"institutionHeld":0,"latestPrice":95.1639,"eps":0,"divideRate":0,"volume":1334,"delay":0,"ttmEps":0,"open":95.37,"prevYearClose":90.4492,"prevWeekClose":95.488,"prevMonthClose":95.2648,"prevQuarterClose":93.4307,"fiveDayClose":95.3184,"twentyDayClose":95.0132,"sixtyDayClose":94.0711},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATTR\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATTR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATTR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATTR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667122668","title":"Why Archer and Joby Stocks Are Falling as Oil and Treasury Yields Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2667122668","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667122668?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:17","pubTimestamp":1789384661,"startTime":"0","endTime":"0","summary":"Archer Aviation Inc. ($ACHR) and Joby Aviation Inc. ($JOBY) fell in premarket trading Monday as a broader risk-off move pressured high-growth stock...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-archer-and-joby-stocks-are-falling-as-oil-and-treasury-yields-rise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-archer-and-joby-stocks-are-falling-as-oil-and-treasury-yields-rise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSMV","DBMF","DSTL","QCLR","DEFN","QDF","BK4008","ISMF","GLDB","SPHD","HFMF","EASY","BK4585","WTMF","BTR","APOC","FDMO","DFNV","TOAK","LGH","CVY","JOBX","SCYB","KSPY","IMOM","HEQ","ATTR","JOBC","MMTM","CGCV","HUSV","BK4603","JLVP","CDC","FAIL","SPHQ","HIGH","JOBY","JPFP","JUNW","CAOS","DMRM","GNAF","TAIL","FFUT","BTAL","QQH","FDLO","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666575754","title":"AstraZeneca’s ATTR-CM Imaging Sub-study Wraps Up, Setting the Stage for New Data Insights","url":"https://stock-news.laohu8.com/highlight/detail?id=2666575754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666575754?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:30","pubTimestamp":1789144211,"startTime":"0","endTime":"0","summary":"AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The CARDIO-TTRansform Scintigraphy Sub-study, officially titled “CARDIO-TT...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-attr-cm-imaging-sub-study-wraps-up-setting-the-stage-for-new-data-insights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-attr-cm-imaging-sub-study-wraps-up-setting-the-stage-for-new-data-insights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116301603","title":"Bond Yields at 5%, Oil at $120, VIX at 25? The Market's Nightmare Scenario Is Rapidly Becoming Reality","url":"https://stock-news.laohu8.com/highlight/detail?id=1116301603","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116301603?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:01","pubTimestamp":1789095704,"startTime":"0","endTime":"0","summary":"The alarm bells ringing in the US bond market are growing impossible to ignore. With the 10-year Treasury yield approaching the critical 5% threshold, an explosive surge in oil prices fueling...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USPX","VTHR","ZFmain","MRCP","ERX","KSPY","UBmain","BSTP","DFUS","TNmain","LDER","DBO","PBSE","QQQY","GUSH","ZHDG","EQL","GVLE","VTG","DRLL","EDGE","VVIX","OILK","DBE","DBC","YSPY","UUP","BKLG","MAYU","BBUS","TVIX","KHPI","DUG","QJN","VAIE","GOVM","OILT","MTUL","ZTmain","SPYU","UAE","SH","USMV","IYY","SPXL","UVIX","IXC","QBQF","SVOL","EBND","VIXmain","TPOR","SSO","PXJ","UDN","AESR","ALTL","BUFD","BWET","BK4581","RSSY","HAPR","BUFT","CAIE","TDAX","USOI","ACLC","SPXT","AAUA","FNDX","SAMM","OCTQ","IUS","ONEO","XVOL","BK4570","PBJA","FLAO","JULD","RSEE","TRTY","FNGS","SCLZ","OAKM","USL","MBCE","MMAR","BK4550","SPY","SPDN","OILU","MBOX","XES","MPAY","ODTE","FTA","FEX","DYNF","RECI","SPHQ","VIXM","WEEI","STOX","MMAX","WTIU","SPYH","QB","FTXN","SMAX","SPYT","TSYX","IVV","JMOM","VIXY","TPAY","VXX","CPNM","CPSM","SCDL","SPXU","WAMA","HEQ","BMVP","BNO","GSUS","WDTE","XLUX","SDS","XLEX","JUNW","BXMX","XNTK","USE","XSPI","FMTM","VIX","XYLG","BK4585","FFLG","GQI","DMAX","OCDB","SPYM","OBIL","UPRO","GSLC","IBTL","PSMR","NYSX","MSTB","FFA","PEJ","UVXY","XDTE","DRIP","SDOG","SVIX","MFMO","DIG","SPUU","SPXS","VOO","CPNQ","BK4196","DECU","ILCB","MSLC","VXMmain","SVXY","VFMO","SCHX","PXE","VDE","SPYQ","IEO","OIH","EXEQ","STRV","BK4588","SPIN","ATTR","ZBmain","QCJA","UJAN","EQTY","HIBL","UTES","IBTB","DECP","VYLD","VXZ","ZNmain","VOOV","FLV","UGA","TVIXF","WBIL","XXV","SIXA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666592301","title":"Intercont says not commenting on short-term market volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2666592301","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666592301?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:25","pubTimestamp":1789053910,"startTime":"0","endTime":"0","summary":"Intercont (NCT) issued an official statement to all shareholders regarding its ongoing business strategy, regulatory compliance framework, and comm...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/intercont-says-not-commenting-on-short-term-market-volatility-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/intercont-says-not-commenting-on-short-term-market-volatility-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNVR","JNEU","DLNV","RISN","QDEF","SEIQ","MAXJ","SPQ","THLV","JULD","HRSK","DMAR","APRJ","FOCT","KAUG","TAOZ","NVBU","OCTM","PBJL","TAIL","RSEE","YSEP","SCY","KHPI","SIXH","APOC","UDEC","MGKX","ATTR","ZHDG","BSR","PKW","TDAX","TECY","AUGZ","PQX","BRKL","DVND","QQQP","XJAN","ZSEP","RJVI","QPX","DLFE","SPYC","JULI","SPUU","BMAY","DDFD","FDLO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114193260","title":"Capital Markets Warns of Rising Odds for a U.S. Stock Correction, Citing Midterm Election Risks and AI Trade Instability","url":"https://stock-news.laohu8.com/highlight/detail?id=1114193260","media":"Deep News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114193260?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:46","pubTimestamp":1788954410,"startTime":"0","endTime":"0","summary":"Strategists at RBC Capital Markets are flagging an increased likelihood of a pullback in U.S. equities of up to 10%, as the country heads into midterm elections and enters a historically soft stretch...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBJL","DMAX","SPXL","UTRN","AGIX","CPSR","ATTR","CPSU","DDFM","GOCT","DOG","SPYM","XBFR","UDOW","DDM","AIPO","SDOW","DIA","MMAX","SPYQ","DDFD","DYHG","BUFR","SPUU","QTOC","SPXS","SH","SPYH","BK4585","IVV","BFRZ","SMAX","XBOC","POCT","UPRO","DDTM","BFEW","SPYU","ALDB","HIBL","RSSE","DXD","BFEB","SSO","DNOV","YSPY","SPXU","UJUL","DDEC","FLAO","DLMY","SDS","SPY","BAPR","FJUL","JANP","UDEC","ARTY","VOO","CHAT","VTHR","BK4588","SPDN","BJUN","DFEB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180229136","title":"Wall Street's Deceptive Calm Meets Bond Market's Stern Warning: As VIX Falls Silent, Are Treasury Yields the New Fear Barometer for Equities?","url":"https://stock-news.laohu8.com/highlight/detail?id=1180229136","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180229136?lang=en_us&edition=fundamental","pubTime":"2026-08-31 11:09","pubTimestamp":1788145789,"startTime":"0","endTime":"0","summary":"As the transition from late summer to early autumn approaches, the apparent tranquility on Wall Street is colliding with multiple escalating risks. Although the traditional fear gauge—the Chicago...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSUS","SDS","ILCB","SPXL","BK4585","IBTL","SPYH","DECU","GVLE","SH","UPRO","BSTP","PBSE","FFLG","ONEO","XNTK","VTHR","WDTE","09141","MBOX","VOO","GOVM","FLV","QQQY","OCTQ","QJN","NYSX","AESR","UTES","UVXY","MMAR","WAMA","MAYU","HAPR","TRTY","DYNF","PBJA","QBQF","MRCP","CPSM","FFA","SCLZ","VAIE","VFMO","ATTR","SPYU","XVOL","EDGE","GQI","FTA","IYY","VTG","JMOM","USMV","CAIE","FLAO","SCDL","SPY","FNDX","MFMO","WBIL","FAZ","SPYQ","TVIX","MLRG","TPAY","KSPY","SAMM","TNmain","IBTB","ZFmain","JULD","FEX","TSYX","BK4588","OBIL","BUFT","FMTM","EXEQ","SVOL","VXMmain","VXX","SPYT","EQL","ODTE","KHPI","SPIN","VIXM","SPHQ","SMAX","DMAX","SPYM","MPAY","ZBmain","MTUL","VYLD","EQTY","03141","ALTL","SPXU","ZHDG","SPUU","SVXY","VIXY","DECP","UVIX","OAKM","USPX","ZTmain","BKLG","SVIX","TDAX","XDTE","BK4581","CPNM","YSPY","VIXmain","HEQ","LDER","AAUA","XYLG","RSSY","XXV","BK4196","EBND","IVV","STOX","UBmain","ZNmain","VXZ","XLUX","QB","SSO","BMVP","STRV","VVIX","MSLC","BK4550","IUS","MBCE","SIXA","SCHX","BUFD","TVIXF","DFUS","XSPI","MMAX","BXMX","FNGS","BBUS","HIBL","MSTB","RSEE","CPNQ","PSMR","JUNW","ACLC","RECI","SPDN","VIX","OCDB","SPXS","QCJA","UJAN","GSLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663047883","title":"BridgeBio Pharma presents new analyses from Phase 3 ATTRibute-CM study","url":"https://stock-news.laohu8.com/highlight/detail?id=2663047883","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663047883?lang=en_us&edition=fundamental","pubTime":"2026-08-31 03:50","pubTimestamp":1788119406,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma (BBIO) presented new analyses from the Phase 3 ATTRibute-CM study of Attruby in transthyretin amyloid cardiomyopathy, ATTR-CM, inc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bridgebio-pharma-presents-new-analyses-from-phase-3-attribute-cm-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bridgebio-pharma-presents-new-analyses-from-phase-3-attribute-cm-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ATTR","BK4505","BBIO","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663004445","title":"Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM","url":"https://stock-news.laohu8.com/highlight/detail?id=2663004445","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663004445?lang=en_us&edition=fundamental","pubTime":"2026-08-30 22:00","pubTimestamp":1788098400,"startTime":"0","endTime":"0","summary":"- Acoramidis is the first therapy shown to potentially reverse cardiac structural disease progression and functional decline through 42 months based on CMR imaging,with up to half of patients showing ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/30/3352965/0/en/acoramidis-demonstrates-reversal-of-cardiac-structural-disease-progression-and-functional-decline-and-significantly-increases-days-alive-and-free-from-hospitalization-in-attr-cm.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA","LU1861219969.SGD","BK4129","BK4081","BK4139","LU1939255532.USD","ARTY","AGIX","LU2308191902.HKD","BK4516","LU2360107325.USD","ACM","QTOC","CHAT","LU0187121727.USD","LU0689626769.HKD","LU2244417387.USD","LU2298064838.USD","LU2238339852.HKD","LU0124676726.USD","ATTR","VTHR","LU1861214812.USD","CVM","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662092949","title":"NZD/USD (NZDUSD) Is down 0.53% on Aug 28: Why It Happened","url":"https://stock-news.laohu8.com/highlight/detail?id=2662092949","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662092949?lang=en_us&edition=fundamental","pubTime":"2026-08-28 23:40","pubTimestamp":1787931618,"startTime":"0","endTime":"0","summary":"• NZDUSD declined due to exhausted RBNZ hawkish expectations and softer domestic data.\n• A firm U.S. dollar gained support from resilient Treasury yields and Fed communications.\n• Technical indicators show neutral MACD and RSI readings with a buy Williams %R.","market":"nz","thumbnail":"https://resource.tradingkey.com/uploads/20260609/cryptocurrencies-1-b7a6e1b561f44c03bdf84bf36737ec73.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260609/cryptocurrencies-1-b7a6e1b561f44c03bdf84bf36737ec73.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262139035-market-movers-nzdusd-20260828","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NZ50G.NZ","US5Y.BOND","FITZ","IMCG","CROC","DIVZ","US12M.BOND","VTV","NZDUSD.FOREX","PSQ","RULE","ITDH","US30Y.BOND","RORO","MFMO","QIS","US10Y.BOND","PLGI","BAMO","SDHY","EQIN","FDLO","KOOL","BKIV","HIDV","US2Y.BOND","VOOV","T10G.NZ","US7Y.BOND","CDC","DVUT","EQRR","FT","DBMF","BAMA","CGDV","CAOS","EMPB","QUSA","EUFX","US3Y.BOND","NZ20C.NZ","ATTR","US6M.BOND","MDPL","WLDR","ET","JULD","EOPS","APOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662093409","title":"Ionis, AstraZeneca ATTR-CM trial did not meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093409","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662093409?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:50","pubTimestamp":1787921430,"startTime":"0","endTime":"0","summary":"The CARDIO-TTRansform trial investigating eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy did not meet its primary effic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ionis-astrazeneca-attr-cm-trial-did-not-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ionis-astrazeneca-attr-cm-trial-did-not-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662973052","title":"Japanese Shares Rise Ahead of Federal Reserve Chair's Rate Outlook; Oil Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2662973052","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662973052?lang=en_us&edition=fundamental","pubTime":"2026-08-28 15:31","pubTimestamp":1787902301,"startTime":"0","endTime":"0","summary":"Japanese stocks gained marginally on Friday after US Treasury yields steadied, while investors remained cautious ahead of Federal Reserve Chair Kevin Warsh's speech at Jackson Hole on the outlook for US interest rates.The benchmark Nikkei 225 closed up 273.58 points, or 0.41%, at 66,405.56.Oil prices extended losses following an Iran-Oman deal to impose a tariff on traffic in the Strait of Hormuz on a revenue-sharing basis, even as hopes of direct US-Iran talks remain uncertain.On the corporate side, Nissan Motor's  global sales fell about 17% year over year to 219,495 units in July, according to a statement on Friday.Also, Toyota Motor  posted its sixth consecutive drop in worldwide monthly sales in July, with group-wide volume falling 5.3% year over year to 912,683 vehicles, according to company data released Friday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BAMO","CGDV","EQRR","JULD","NELS","CAOS","SOVF","MFMO","BKIV","QIS","ARKD","BINT","SGRT","US10Y.BOND","MDPL","EOPS","RJZ","DADS","PLGI","SDHY","US12M.BOND","WLDR","HIDV","EQIN","DVUT","NSCI","SLTY","SPBW","FT","VOOV","LQ","DBMF","EMPB","ITDH","EBND","PEMX","VEXC","ATTR","VTV","RORO","PSQ","FITZ","RGLO","RULE","KOOL","BAMA","CDIG","HF","QUSA","OGSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662181084","title":"Bayer’s MOSAIC-TTR Study: Real-World Data Push for Acoramidis in ATTR-CM","url":"https://stock-news.laohu8.com/highlight/detail?id=2662181084","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662181084?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:31","pubTimestamp":1787848296,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY) announced an update on their ongoing clinical study. The MOSAIC-TTR study, officially titled “A Prospective, Longitudinal, Multi-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bayers-mosaic-ttr-study-real-world-data-push-for-acoramidis-in-attr-cm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bayers-mosaic-ttr-study-real-world-data-push-for-acoramidis-in-attr-cm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662468716","title":"BridgeBio Pharma doses first patient in ASCEND-ATTR trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662468716","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662468716?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:45","pubTimestamp":1787744721,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma (BBIO) announced that the first participant has been dosed in ASCEND-ATTR, a Phase 3b/4 study designed to further characterize the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bridgebio-pharma-doses-first-patient-in-ascend-attr-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bridgebio-pharma-doses-first-patient-in-ascend-attr-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4139","ATTR","BK4585","BK4588","BBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715763","title":"BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715763","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662715763?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:30","pubTimestamp":1787743800,"startTime":"0","endTime":"0","summary":"- The ASCEND-ATTR study builds on the Phase 3 ATTRibute-CM CMR substudy results previously shared here, which indicated treatment with acoramidis may improve cardiac structure and function with eviden","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351235/0/en/bridgebio-announces-first-participant-dosed-in-ascend-attr-a-phase-3b-4-study-evaluating-the-long-term-effects-of-acoramidis-on-disease-regression-in-attr-cm.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATTR","BK4207","CM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178549106","title":"Alert Signals Intensify: UBS Flags U.S. Stock Market Fragility at Two-Year High, Echoing Pattern That Preceded VIX Spike","url":"https://stock-news.laohu8.com/highlight/detail?id=1178549106","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178549106?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:07","pubTimestamp":1787656034,"startTime":"0","endTime":"0","summary":"Fragility is quietly building within the U.S. stock market. On August 25, MarketWatch reported that UBS's \"Turbu-lens\" index, a proprietary gauge designed to measure market fragility, has recently...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SDS","IVV","SPXL","SVOL","BK4585","VXMmain","SPYH","DECU","VXX","SH","SSO","UPRO","VXZ","ODTE","ATTR","SPYU","VVIX","VIXM","SMAX","USMV","DMAX","SPYM","WDTE","FLAO","VYLD","SPXU","ZHDG","TVIXF","SPUU","SPY","DFUS","SVXY","VIXY","VOO","MMAX","QQQY","DECP","OCTQ","UVIX","HIBL","SPYQ","MSTB","TVIX","SPDN","SVIX","VIX","XDTE","UVXY","SPXS","YSPY","BK4588","VIXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279552","title":"Alnylam to present new clinical data on ATTR, hypertension at ESC Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279552","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279552?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575225,"startTime":"0","endTime":"0","summary":"Alnylam (ALNY) Pharmaceuticals announced that it will present new clinical and real-world data across its transthyretin-mediated amyloidosis, ATTR,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-to-present-new-clinical-data-on-attr-hypertension-at-esc-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-to-present-new-clinical-data-on-attr-hypertension-at-esc-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GNMX","LU0109394709.USD","ALNY","PBE","BK4548","BK4588","ATTR","LU0114720955.EUR","LU0320765992.SGD","LU0889565916.HKD","LU0882574055.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275001","title":"BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275001","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275001?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:30","pubTimestamp":1787571000,"startTime":"0","endTime":"0","summary":"PALO ALTO, Calif., Aug.  24, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic cond","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349646/0/en/bridgebio-to-present-new-acoramidis-data-from-open-label-extension-analyses-in-attr-cm-at-esc-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","CM","EMA","ATTR","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660447732","title":"The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447732","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447732?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:22","pubTimestamp":1787138520,"startTime":"0","endTime":"0","summary":"Strategist Mark Newton flags signs of technical resilienceResilient financial stocks are one signal the bond-market rout won't drive a bigger equity selloff, says Fundstrat.While the bond market sello","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVIX","SPYQ","US6M.BOND","USMV","VXZ","SKHX","TMF","US5Y.BOND","US30Y.BOND","VIXY","SVOL","ATTR","SPUU","SKHZ","SPXU","DMAX","US12M.BOND","SKHY","SPY","US2Y.BOND","IVV","FLAO","LOW","US3Y.BOND","VYLD","TVIXF","VVIX","HYNX","SKHU","SPYH","UPRO","SPDN","YSPY","SKDD","SPXS","US10Y.BOND","TLT","US7Y.BOND","SKHYV","SH","TLTW","VIXmain","HIBL","VIXM","SPXL","SKUU","SPYU","TJX","ISBC","SMAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657598758","title":"Banco Santander receives Federal Reserve approval for Webster acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2657598758","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657598758?lang=en_us&edition=fundamental","pubTime":"2026-08-05 07:00","pubTimestamp":1785884429,"startTime":"0","endTime":"0","summary":"Banco Santander (SAN) and Webster Financial (WBS) announced that they have received the required approval from the Board of Governors of the Federa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/banco-santander-receives-federal-reserve-approval-for-webster-acquisition-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/banco-santander-receives-federal-reserve-approval-for-webster-acquisition-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CPNM","FLSP","US7Y.BOND","SPBW","SSEUF","BGH","CAOS","QUSA","FLDZ","ZSEP","US10Y.BOND","GDMA","JPO","QIS","PLGI","DVUT","AMZY","ARKD","CGDV","ATTR","FITZ","SOVF","WLDR","AAUB","BUFH","PSQ","VTV","OGSP","EQIN","US30Y.BOND","FDLO","HF","WBS","BINT","US12M.BOND","GXDW","SCLZ","US3Y.BOND","ISSXF","BAMO","EQRR","EOPS","SLTY","NELS","OCTU","HFEQ","LALT","LVLN","DBMF","PAYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655361590","title":"A Federal Reserve Stuck in Limbo","url":"https://stock-news.laohu8.com/highlight/detail?id=2655361590","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655361590?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:15","pubTimestamp":1785503700,"startTime":"0","endTime":"0","summary":"Federal Reserve Chairman Kevin Warsh's second press conference this week left many confused, including reporters and economists like me who closely follow the Fed. Markets temporarily reacted negative","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FT","US3Y.BOND","ITDH","KHPI","US7Y.BOND","BUFH","EQRR","RAAA","DBMF","US30Y.BOND","US12M.BOND","RULE","HF","FITZ","OGSP","US6M.BOND","AMZY","EBND","QIS","SLTY","BAMO","FLSP","LQ","SCLZ","NQLT","SIXH","SPBW","VEXC","ATTR","DVUT","PLGI","FARX","CGDV","EOPS","US2Y.BOND","US5Y.BOND","EQIN","RGLO","VTV","JULD","GDMA","MFMO","US10Y.BOND","PAYH","PBQQ","HIDV","OCTM","NELS","BAMA","ARKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}